https://pharmadog.xyz/news/562371 pharmadog en 2026-10-19T06:00:32.000Z Nouscom secures $135 million Series D to advance lead cancer vaccine into Phase 2 https://pharmadog.xyz/news/562119 pharmadog en 2026-10-19T05:00:00.000Z Sino Biological offers validated cytokines to improve organoid culture and research https://pharmadog.xyz/news/561951 pharmadog en 2026-10-19T04:18:00.000Z Merck/Moderna vaccine and Summit/Akeso bispecific therapy among key highlights at ESMO 2026 https://pharmadog.xyz/news/561952 pharmadog en 2026-10-19T04:02:00.000Z Experts tout amylin as promising, potentially gentler obesity target as new combo therapies near FDA review https://pharmadog.xyz/news/561953 pharmadog en 2026-10-19T04:01:00.000Z Multispecific drug design faces growing complexity as more binding arms increase molecular options https://pharmadog.xyz/news/561299 pharmadog en 2026-10-19T00:54:03.000Z Cambridge biologist David Sabatini awarded $6 million after jury rejects harassment claims https://pharmadog.xyz/news/553359 pharmadog en 2026-10-17T10:00:16.000Z Endpoints Weekly highlights search for Alzheimer’s ‘statin’, Arrowhead’s tau-lowering injectable and AI Day recap